Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of methadone metabolites for treatment of anxiety and depression

Use of methadone metabolites for treatment of anxiety and depression

US Patent 11278522 · Granted Mar 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of methadone metabolites for treatment of anxiety and depression2020
Use of methadone metabolites for treatment of anxiety and depression2020
Use of methadone metabolites for treatment of anxiety and depression2020
2-halo-5-alkynyl-pyridyl nicotinic ligands2019
2-halo-5-alkynyl-pyridyl nicotinic ligands2019
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof2018
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2018
2-halo-5-alkynyl-pyridyl nicotinic ligands2018
2-halo-5-alkynyl-pyridyl nicotinic ligands2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2016